Tariff Risks Archives | Be Korea-savvy

Korean Pharma Sees Opportunity in Trump’s U.S. Drug Price Reform, Despite Tariff Risks

SEOUL, May 14 (Korea Bizwire) — South Korea’s pharmaceutical and biotech companies view the Trump administration’s push to lower U.S. prescription drug prices as a potential tailwind for domestic drugmakers, particularly those in the biosimilar space. Former President Donald Trump, who is expected to run again in the 2026 election, issued an executive order last week [...]

Genesis Sales Surge in U.S., But Tariff Risks Loom

SEOUL, March 17 (Korea Bizwire) — Hyundai Motor’s luxury brand Genesis is seeing unprecedented success in the U.S. market, where it accounted for nearly one-third of global sales last year. However, potential tariff barriers under a new Trump administration pose a significant challenge to sustaining this growth. According to Hyundai’s latest Investor Relations (IR) report, Genesis [...]